Following the recommendation, InflaRx intends to halt further development of vilobelimab for the PG indication. The company ...

The small molecule drug, acquired by Jazz Pharmaceuticals in its $935 million Chimerix pick-up this spring, is intended for ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

The U.S. Food and Drug Administration said on Wednesday that it has approved Jazz Pharmaceuticals' drug to treat diffuse ...

Dordaviprone (Modeyso) is now approved to treat recurrent H3 K27M-mutant diffuse midline glioma, an ultra-rare, aggressive ...

The FDA granted accelerated approval to dordaviprone (Modeyso) as the first systemic therapy for adults and children with ...

A new treatment has received a quick federal nod for a common blood cancer, which could affect more than 36,000 people and result in around 12,000 deaths in the U.S. this year alone.

FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough New treatment offers dogs year-round protection with a single shot.

LIMA — Mercy Health-St. Rita’s Medical Center now offers non-surgical treatment for tricuspid regurgitation or leaky heart valve, a condition in which one of the heart’s valves doesn’t ...

New treatment offers dogs year-round protection with a single shot.

We talk to Dr. David Clarke, president of the Association for the Treatment of Neuroplastic Symptoms, about a new therapy that is more effective than conventional methods of treating chronic pain.

Stanford Medicine has opened a new outpatient clinic and infusion center at the Lucile Packard Children’s Hospital, adding six new exam rooms and 15 private infusion bays for patients and families.